• Small Molecules
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

News & Events

Syngene announces senior-level appointments Strengthens leadership in USA
4th Aug, 2021
Syngene reports first quarter results Revenue from operations up 41% to Rs. 5,945 Mn, PAT increased 33% to Rs. 773 Mn
20th Jul, 2021
Syngene appoints Sanjeev Sukumaran as CHRO
3rd Jun, 2021
Syngene reports revenue from operations growth of 13% in the fourth quarter; 12% for the full year
27th Apr, 2021
Syngene International extends long term research collaboration with Bristol Myers Squibb until 2030
26th Apr, 2021
Inauguration of COVID-19 Vaccination Centre at Syngene International Limited, Biocon Group of Companies
12th Apr, 2021
Syngene announces Q3 FY21 results
20th Jan, 2021
Syngene and PharmAust collaborate to manufacture GMP-grade Monepantel for Human Clinical Trials
23rd Dec, 2020
Syngene and Deerfield Discovery and Development (3DC) sign 5-year strategic collaboration
19th Nov, 2020
Syngene reports second quarter revenue from operations at Rs. 519 Cr, up 12% year on year
21st Oct, 2020
Syngene joins global industry consortium to accelerate collaborative research in COVID-19 testing
1st Oct, 2020
Syngene leads the way in organisational safety with proactive COVID-19 testing for all employees
29th Sep, 2020
ICMR approval for HiMedia-Syngene COVID-19 antibody test kit, ELISafe 19™
9th Sep, 2020
Syngene announces Q1 FY21 results
21st Jul, 2020
Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits for COVID-19
2nd Jun, 2020
Syngene reports solid Q4 growth and ends the year on a strong note
12th May, 2020
Syngene International opens COVID-19 RT-PCR testing centre to support Bengaluru hospitals
27th Apr, 2020
Syngene pitches in with indigenous antibody test kits
6th Apr, 2020
Essential research and critical manufacturing operations to continue at Syngene International in compliance with Government of India directives and classification as an “essential” industry
25th Mar, 2020
Minister K.T Rama Rao inaugurates Syngene’s new R&D centre in Genome Valley, Hyderabad
18th Feb, 2020

To download, Please share your details

To download, Please share your details